Cancer cell metabolism: Rewiring the mitochondrial hub

• Autor(a) principal: Oliveira, Gabriela L.
• Data de Publicação: 2021
• Outros Autores: Coelho, Ana R., Marques, Ricardo, Oliveira, Paulo J.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10316/95483; https://doi.org/10.1016/j.bbadis.2020.166016
• topic: Cancer; Metabolic pathways; Metabolism; Mitochondria; mtDNA; Antineoplastic Agents; DNA, Mitochondrial; Drug Resistance, Neoplasm; Humans; Mitochondria; Neoplasm Staging; Neoplasms; Oxidative Phosphorylation; Prognosis; Signal Transduction; Tumor Microenvironment; Warburg Effect, Oncologic

To adapt to tumoral environment conditions or even to escape chemotherapy, cells rapidly reprogram their metabolism to handle adversities and survive. Given the rapid rise of studies uncovering novel insights and therapeutic opportunities based on the role of mitochondria in tumor metabolic programing and therapeutics, this review summarizes most significant developments in the field. Taking in mind the key role of mitochondria on carcinogenesis and tumor progression due to their involvement on tumor plasticity, metabolic remodeling, and signaling re-wiring, those organelles are also potential therapeutic targets. Among other topics, we address the recent data intersecting mitochondria as of prognostic value and staging in cancer, by mitochondrial DNA (mtDNA) determination, and current inhibitors developments targeting mtDNA, OXPHOS machinery and metabolic pathways. We contribute for a holistic view of the role of mitochondria metabolism and directed therapeutics to understand tumor metabolism, to circumvent therapy resistance, and to control tumor development.